Efficacy of endoscopic injection of snake venom hemocoagulase combined with intravenous drip of omeprazole in the treatment of ulcerative upper gastrointestinal bleeding
-
摘要:
目的 分析内镜下注射蛇毒血凝酶联合静脉滴注奥美拉唑治疗溃疡性上消化道出血的疗效。 方法 选取2019年5月~2022年5月于本院接受治疗的溃疡性上消化道出血患者126例作为研究对象,依据入院先后顺序分为对照组和研究组,63例/组。对照组给予奥美拉唑静脉滴注治疗,40 mg/次,2次/d;研究组在此基础上于出血部位周围或断端血管内注射蛇毒血凝酶,1~2 U/d,两组均连续治疗5 d。比较两组止血时间、再出血率、转手术率、住院时间,比较两组治疗前后凝血功能指标[凝血酶原时间(PT)、部分活化凝血酶原时间(APTT)、D-二聚体(D-D)、纤维蛋白原(FIB)]水平、血流动力学指标[收缩压(SBP)、舒张压(DBP)、心率(HR)]变化,并分析临床疗效和安全性。 结果 研究组的止血时间、再出血率、转手术率、住院时间均较对照组降低(P < 0.05);治疗后,两组的PT、APTT较治疗前均降低,D-D、FIB较治疗前均升高(P < 0.05),且研究组PT、APTT水平低于对照组,D-D、FIB水平高于对照组(P < 0.05);治疗后,两组SBP、DBP、HR值较治疗前均降低(P < 0.05),且研究组SBP、DBP、HR值高于对照组(P < 0.05)。研究组的治疗总有效率为95.24%,高于对照组的79.36%(P < 0.05);研究组的不良反应总发生率为6.35%,与对照组的(12.70%)差异无统计学意义(P > 0.05)。 结论 应用内镜下注射蛇毒血凝酶联合静脉滴注奥美拉唑治疗溃疡性上消化道出血的止血效果显著,能明显降低患者再出血率、转手术率,有效改善患者凝血功能指标,维持患者血压及心率稳定,安全性高。 Abstract:Objective To analyze the efficacy of endoscopic injection of snake venom hemocoagulase combined with intravenous drip of omeprazole in the treatment of ulcerative upper gastrointestinal bleeding. Methods A total of 126 patients with ulcerative upper gastrointestinal bleeding who were treated in our hospital from May 2019 to May 2022 were selected. They were divided into the control group (n=63) and the research group (n=63) according to the order of admission. The control group was given omeprazole intravenous drip treatment, 40 mg/time, 2 times per day. The research group was given intravascular injection of snake venom hemocoagulase around the bleeding site or the broken end on this basis, 1-2 U/d, both groups received continuous treatment for 5 d. Hemostasis time, rebleeding rate, the rate of transfer to surgery and hospitalization time between the two groups were compared, the coagulation function indexes [prothrombin time (PT), partially activated prothrombin time (APTT), D-dimer (D-D), fibrinogen (FIB)] levels, hemodynamic indexes [systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR)] changes were compared between the two groups before and after treatment, and the clinical efficacy and safety were analyzed. Results The hemostasis time, rebleeding rate, rate of transfer to surgery, and hospital stay in the research group were significantly lower than those in the control group (P < 0.05). After treatment, the PT and APTT of the two groups were lower than those before treatment, and the D-D and FIB were higher than those before treatment (P < 0.05). The levels of PT and APTT in the research group were lower than those in the control group, while the levels of D-D and FIB were higher than those in the control group (P < 0.05). After treatment, the SBP, DBP and HR values of the two groups were all lower than those before treatment (P < 0.05). The SBP, DBP and HR values of the research group were significantly higher than those of the control group (P < 0.05). The total effective rate of the research group was significantly higher than that of the control group (P < 0.05). The total incidence of adverse reactions in the research group was not significantly different from the control group (P > 0.05). Conclusion Endoscopic injection of snake venom hemocoagulase combined with intravenous infusion of omeprazole has a significant hemostatic effect in the treatment of ulcerative upper gastrointestinal bleeding. It can significantly reduce the rate of rebleeding and transfer to surgery, effectively improve the coagulation function indexes of patients, and maintain the stability of blood pressure and heart rate of patients. -
表 1 两组止血时间、输血量、住院时间、再出血率比较
Table 1. Comparison of hemostasis time, transfusion volume, hospital stay, and rebleeding rate between the two groups (n=63)
组别 止血时间(h, Mean±SD) 住院时间(d, Mean±SD) 再出血率[n(%)] 转手术率[n(%)] 研究组 23.16±4.26 4.35±1.08 2(3.17) 1(1.59) 对照组 31.77±6.24 5.47±1.27 9(14.29) 8(12.70) t/χ2 9.045 5.332 4.881 5.862 P < 0.001 < 0.001 0.027 0.015 表 2 两组凝血功能指标比较
Table 2. Comparison of coagulation function indexes between the two groups (n=63, Mean±SD)
组别 PT(s) APTT(s) D-D(µg/mL) FIB(g/L) 治疗前 治疗后 治疗前 治疗后 治疗前 治疗后 治疗前 治疗后 研究组 12.33±2.51 8.33±1.53α 30.25±6.59 27.17±2.26α 2.67±0.51 4.08±0.48α 3.22±0.75 3.96±0.26α 对照组 12.45±2.36 10.22±2.01α 31.06±5.77 29.32±3.54α 2.78±0.56 3.26±0.52α 3.31±0.47 3.76±0.31α t 0.276 5.939 0.734 4.063 1.153 9.197 0.807 3.924 P 0.783 < 0.001 0.464 < 0.001 0.251 < 0.001 0.421 < 0.001 αP < 0.05 vs同组治疗前. PT: 凝血酶原时间; APTT: 部分活化凝血酶原时间; D-D: D-二聚体; FIB: 纤维蛋白原. 表 3 两组血流动力学指标比较
Table 3. Comparison of hemodynamic indexes between the two groups (n=63, Mean±SD)
组别 SBP(mmHg) DBP(mmHg) HR(次/min) 治疗前 治疗后 治疗前 治疗后 治疗前 治疗后 研究组 107.48±5.47 100.37±3.51α 81.25±4.34 67.69±3.35α 101.26±3.64 94.24±3.34α 对照组 106.86±5.49 91.44±3.43α 80.57±4.81 60.67±2.29α 101.58±3.74 85.77±3.01α t 0.635 14.443 0.816 13.731 0.487 14.952 P 0.527 < 0.001 0.416 < 0.001 0.627 < 0.001 αP < 0.05 vs同组治疗前. SBP: 收缩压; DBP: 舒张压; HR: 心率. 表 4 两组临床疗效比较
Table 4. Comparison of the clinical efficacy between the two groups [n=63, n(%)]
组别 显效 有效 无效 总有效率 研究组 37(58.73) 23(36.51) 3(4.76) 60(95.24) 对照组 29(46.03) 21(33.33) 13(20.63) 50(79.36) χ2 7.719 P 0.007 -
[1] Sung JJ, Chiu PW, Chan FKL, et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018[J]. Gut, 2018, 67(10): 1757-68. doi: 10.1136/gutjnl-2018-316276 [2] 屈海燕, 强文娟, 阿英. 泮托拉唑联合胃镜喷洒血凝酶治疗消化性溃疡合并出血的效果分析[J]. 解放军医药杂志, 2020, 32(5): 73-7. doi: 10.3969/j.issn.2095-140X.2020.05.018 [3] 王时峰, 郭月皓, 谢艳. 奥美拉唑联合奥曲肽与胃镜辅助联合药物治疗胃出血患者的复发率差异研究[J]. 中国药物与临床, 2019, 19(6): 860-2. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201906002.htm [4] 匡大鹏. 胃镜下不同止血方式治疗急性非静脉曲张上消化道出血的回顾性分析[J]. 现代消化及介入诊疗, 2017, 22(3): 346-8. doi: 10.3969/j.issn.1672-2159.2017.03.016 [5] Boldrini-França J, Pinheiro-EL Jr, Peigneur S, et al. Beyond hemostasis: a potassium channel blocker snake venom serine protease with potential antitumor activity[J]. Toxicon, 2020, 177: S8-9. [6] 田洁, 李晓兰, 周栩茹, 等. 蛇毒血凝酶联合缩宫素治疗高龄产妇剖宫产术后出血的临床研究[J]. 现代药物与临床, 2019, 34(2): 472-6. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW201902044.htm [7] 《中华内科杂志》编辑委员会, 《中华医学杂志》编辑委员会, 《中华消化杂志》编辑委员会, 等. 急性非静脉曲张性上消化道出血诊治指南(2018年, 杭州) [J]. 中华内科杂志, 2019, 58(3): 173-80. doi: 10.3760/cma.j.issn.0578-1426.2019.03.005 [8] 郑兰芬, 张明霞, 孟祥武. 实用内科诊断治疗学[M]. 长春: 吉林科学技术出版社, 2013. [9] Toka B, Eminler AT, Karacaer C, et al. Comparison of monopolar hemostatic forceps with soft coagulation versus hemoclip for peptic ulcer bleeding: a randomized trial (with video)[J]. Gastrointest Endosc, 2019, 89(4): 792-802. doi: 10.1016/j.gie.2018.10.011 [10] Butler E, Møller MH, Cook O, et al. The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis[J]. Intensive Care Med, 2019, 45(11): 1540-9. doi: 10.1007/s00134-019-05754-3 [11] 马丽, 王学莉, 王成立, 等. 高剂量生长抑素、奥美拉唑联合止血芳酸治疗急性上消化道出血合并凝血功能障碍患者的临床效果[J]. 现代生物医学进展, 2018, 18(14): 2746-9, 2791. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201814032.htm [12] 潘奇俊, 陆有娇, 杨妮青. 胃镜下止血铗与奥美拉唑联合铝碳酸镁治疗胃十二指肠溃疡并出血的效果观察[J]. 智慧健康, 2018, 4 (22): 41-3. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHJK201822019.htm [13] Chwiesko A, Charkiewicz R, Niklinski J, et al. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: a randomized prospective study[J]. J Dig Dis, 2016, 17(9): 588-99. doi: 10.1111/1751-2980.12393 [14] 薛杰. 奥曲肽联合蛇毒血凝酶治疗乙肝后肝硬化合并上消化道出血疗效观察[J]. 智慧健康, 2019, 5(19): 48-9, 55. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHJK201919022.htm [15] Amorim FG, Menaldo DL, Carone SEI, et al. New insights on moojase, a thrombin-like serine protease from Bothrops moojeni snake venom[J]. Toxins, 2018, 10(12): 500. [16] 严明科, 鲍磊, 王迎新, 等. 白眉蛇毒血凝酶联合泮托拉唑在上消化道出血患者中的作用机制研究[J]. 海南医学院学报, 2017, 23(3): 345-8, 352. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201703017.htm [17] 黄君群. 注射用白眉蛇毒血凝酶联合奥美拉唑钠治疗消化性溃疡并发出血的疗效观察[J]. 临床合理用药杂志, 2014, 7(15): 60-1. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201415046.htm [18] 薛金菊, 崔晓红, 邢梦芸. 白眉蛇毒血凝酶联合注射用艾司奥美拉唑钠治疗老年急性上消化道出血疗效研究[J]. 创伤与急危重病医学, 2021, 9(2): 153-5. https://www.cnki.com.cn/Article/CJFDTOTAL-CSJB202102021.htm [19] Lo GH, Lin CW, Tai CM, et al. A prospective, randomized trial of thrombin versus cyanoacrylate injection in the control of acute gastric variceal hemorrhage[J]. Endoscopy, 2020, 52(7): 548-55. [20] Luo XF, Xiang T, Wu JC, et al. Endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration for prevention of gastric variceal bleeding: a randomized controlled trial [J]. Hepatology, 2021, 74(4): 2074-84. [21] 符益, 朱材忠, 吴素江, 等. 奥美拉唑联合蛇毒血凝酶治疗消化道溃疡大出血的临床疗效研究[J]. 山西医药杂志, 2017, 46(8): 923-5. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201708029.htm [22] 孙东梅. 胃镜下钛夹止血联合奥美拉唑治疗溃疡性上消化道出血的疗效观察[J]. 临床研究, 2021, 29(8): 19-21. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYN202108010.htm